FDA Brief

Warning letters Food

FDA warning letter to

Spartan Enterprises Inc. dba Watershed Wellness Center

High riskIssued Mar 8, 2023Posted Apr 25, 2023Division of Human and Animal Food Operations East VI

FDA warned Spartan Enterprises/Watershed Wellness that its Dr. Bob’s Naturals supplements are unapproved drugs and are made under CGMP violations.

What happened

FDA inspected the dietary supplement facility in Lansing, Michigan, from June 29 through July 25, 2022, and reviewed websites and a YouTube channel in December 2022. FDA found labels, websites, and videos claiming the products treat diseases such as cancer, Alzheimer’s, kidney stones, and infections, making them unapproved new drugs. The inspection also found current good manufacturing practice (CGMP) violations, including missing specifications, incomplete manufacturing and batch records, and unsanitary conditions.

What FDA found

  1. FDA says the products are unapproved new drugs because labels and promotions claim they cure, mitigate, treat, or prevent diseases.

    21 U.S.C. §§ 321(g)(1)(B), 321(p), 331(d), 355(a)
  2. FDA says some products are misbranded because they lack adequate directions for a layperson to use them safely for serious diseases.

    21 U.S.C. § 352(f)(1); 21 CFR 201.5
  3. FDA says the company did not set required component and finished-product specifications for identity, purity, strength, composition, and contamination limits.

    21 CFR 111.70(b)(2), 111.70(e)
  4. FDA says master manufacturing records omitted required details such as ingredient identity and weight, theoretical yield, packaging and labeling instructions, and corrective actions.

    21 CFR 111.205(a), 111.210
  5. FDA says batch production records omitted required details such as equipment identity, cleaning dates and times, component identifiers, yields, test results, and quality-control release documentation.

    21 CFR 111.255(a), 111.260
  6. FDA says the plant was not clean and sanitary, with residue on vents and ceiling tiles and stains on walls, and cleaning procedures did not cover ceiling tiles.

    21 CFR 111.15(b)(1)

What FDA wants

FDA tells the company to correct the violations and provide documentation, such as specifications and revised manufacturing and batch records, to show the fixes. The provided letter text does not state a response deadline.

Who should pay attention

  • brands selling Dr. Bob’s Naturals or Raw Food World supplements
  • dietary supplement contract manufacturers and repackers
  • retailers and consumers using supplements promoted for serious disease treatment

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk